Does NIVOLUMAB Cause Hemiparesis? 111 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 111 reports of Hemiparesis have been filed in association with NIVOLUMAB (OPDIVO). This represents 0.1% of all adverse event reports for NIVOLUMAB.
111
Reports of Hemiparesis with NIVOLUMAB
0.1%
of all NIVOLUMAB reports
15
Deaths
83
Hospitalizations
How Dangerous Is Hemiparesis From NIVOLUMAB?
Of the 111 reports, 15 (13.5%) resulted in death, 83 (74.8%) required hospitalization, and 6 (5.4%) were considered life-threatening.
Is Hemiparesis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NIVOLUMAB. However, 111 reports have been filed with the FAERS database.
What Other Side Effects Does NIVOLUMAB Cause?
Death (11,216)
Malignant neoplasm progression (9,363)
Off label use (5,208)
Diarrhoea (4,692)
Fatigue (3,709)
Pyrexia (3,454)
Intentional product use issue (3,297)
Rash (2,816)
Nausea (2,805)
Decreased appetite (2,619)
What Other Drugs Cause Hemiparesis?
ASPIRIN (538)
FINGOLIMOD (534)
METHOTREXATE (534)
RIVAROXABAN (363)
PREDNISONE (359)
METFORMIN (353)
DIMETHYL (345)
RITUXIMAB (331)
CLOPIDOGREL BISULFATE (327)
ATORVASTATIN (317)
Which NIVOLUMAB Alternatives Have Lower Hemiparesis Risk?
NIVOLUMAB vs NIVOLUMAB\RELATLIMAB-RMBW
NIVOLUMAB vs NIZATIDINE
NIVOLUMAB vs NOMEGESTROL
NIVOLUMAB vs NORDAZEPAM
NIVOLUMAB vs NOREPINEPHRINE